Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study
DOI:
https://doi.org/10.2340/actadv.v104.11917Keywords:
Children, Epidermolysis bullosa acquisita, Clinical feature, Histopathology, TherapyAbstract
Epidermolysis bullosa acquisita (EBA) rarely develops in childhood. This study retrospectively recruited paediatric patients with EBA (age ≤ 16 years), diagnosed by clinical and histopathological features and results of immunofluorescence, immunoblotting and enzyme-linked immunosorbent assay (ELISA), and reviews their clinical manifestations, histopathology, immunological features, and responses to various treatments. All 7 included patients presented with inflammatory EBA. Among them, 3 had a bullous pemphigoid-like phenotype. Pathologically, in addition to dermal–epidermal blistering, in all patients, the distribution of neutrophils was superficial perivascular or interstitial, or in the dermal papilla. Mixed neutrophils and eosinophils were detected in 2 of the 3 patients with bullous pemphigoid-like phenotypes. In addition to treatment with glucocorticoids, dapsone was administered in 4 patients, while thalidomide and sulfasalazine were administered in 1 patient. All patients responded to the these therapies. Relapse was mainly due to reduction and cessation of glucocorticoids. In conclusion, EBA in childhood may be unique, and thus distinct from its adult counterpart. Specific treatment and follow-up protocols are required for therapy of this rare autoimmune skin disease in children.
Downloads
References
Papara C, Karsten CM, Ujiie H, Schmidt E, Schmidt-Jiménez LF, Baican A, et al. The relevance of complement in pemphigoid diseases: a critical appraisal. Front Immunol 2022; 13: 973702.
https://doi.org/10.3389/fimmu.2022.973702 DOI: https://doi.org/10.3389/fimmu.2022.973702
Elliott GT. Two cases of epidermolysis bullosa. J Cutan Genitourin Dis 1895; 13: 10-18.
Kablitz R. Ein Beitrag Zur Frage der Epidermolysis bullosa (heriditaria et acquisita). These Inaug Rostock Diss 1904.
Roenigk HHJ, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol 1971; 103: 1-10. DOI: https://doi.org/10.1001/archderm.103.1.1
https://doi.org/10.1001/archderm.1971.04000130003001 DOI: https://doi.org/10.1001/archderm.1971.04000130003001
Vorobyev A, Ludwig RJ, Schmidt E. Clinical features and diagnosis of epidermolysis bullosa acquisita. Expert Rev Clin Immunol 2017; 13: 157-169.
https://doi.org/10.1080/1744666X.2016.1221343 DOI: https://doi.org/10.1080/1744666X.2016.1221343
Kim JH, Kim YH, Kim SC. Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases. Acta Derm Venereol 2011; 91: 307-312.
https://doi.org/10.2340/00015555-1065 DOI: https://doi.org/10.2340/00015555-1065
Hübner F, König IR, Holtsche MM, Zillikens D, Linder R, Schmidt E. Prevalence and age distribution of pemphigus and pemphigoid diseases among paediatric patients in Germany. J Eur Acad Dermatol Venereol 2020; 34: 2600-2605.
https://doi.org/10.1111/jdv.16467 DOI: https://doi.org/10.1111/jdv.16467
Iwata H, Vorobyev A, Koga H, Recke A, Zillikens D, Prost-Squarcioni C, et al. Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients. Orphanet J Rare Dis 2018; 13: 153.
https://doi.org/10.1186/s13023-018-0896-1 DOI: https://doi.org/10.1186/s13023-018-0896-1
Guerra L, Pacifico V, Calabresi V, De Luca N, Castiglia D, Angelo C, et al. Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata. Br J Dermatol 2017; 176: 491-494.
https://doi.org/10.1111/bjd.14764 DOI: https://doi.org/10.1111/bjd.14764
Iranzo P, Herrero-González JE, Mascaró-Galy JM, Suárez-Fernández R, España A. Epidermolysis bullosa acquisita: a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain. Br J Dermatol 2014; 171: 1022-1030.
https://doi.org/10.1111/bjd.13144 DOI: https://doi.org/10.1111/bjd.13144
Prost-Squarcioni C, Caux F, Schmidt E, Jonkman MF, Vassileva S, Kim SC, et al. International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita. Br J Dermatol 2018; 179: 30-41.
https://doi.org/10.1111/bjd.16138 DOI: https://doi.org/10.1111/bjd.16138
Ludwig RJ. Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol 2013; 2013: 812029.
https://doi.org/10.1155/2013/812029 DOI: https://doi.org/10.1155/2013/812029
Kim JH, Kim YH, Kim S, Noh EB, Kim SE, Vorobyev A, et al. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions. J Eur Acad Dermatol Venereol 2013; 27: e224-230.
https://doi.org/10.1111/j.1468-3083.2012.04617.x DOI: https://doi.org/10.1111/j.1468-3083.2012.04617.x
Hignett E, Sami N. Pediatric epidermolysis bullosa acquisita: a review. Pediatr Dermatol 2021; 38: 1047-1050.
https://doi.org/10.1111/pde.14722 DOI: https://doi.org/10.1111/pde.14722
Rashid H, Lamberts A, Borradori L, Alberti-Violetti S, Barry RJ, Caproni M, et al. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I. J Eur Acad Dermatol Venereol 2021; 35: 1750-1764.
https://doi.org/10.1111/jdv.17397 DOI: https://doi.org/10.1111/jdv.17397
Schmidt E, Rashid H, Marzano AV, Lamberts A, Di Zenzo G, Diercks GFH, et al. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. J Eur Acad Dermatol Venereol 2021; 35: 1926-1948.
https://doi.org/10.1111/jdv.17395 DOI: https://doi.org/10.1111/jdv.17395
Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, et al. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol 2012; 66: 479-485.
https://doi.org/10.1016/j.jaad.2011.06.032 DOI: https://doi.org/10.1016/j.jaad.2011.06.032
Baykal C, Okan G, Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol 2001; 44: 348-350.
https://doi.org/10.1067/mjd.2001.103034 DOI: https://doi.org/10.1067/mjd.2001.103034
Oranje AP, Vuzevski VD, van Joost T, ten Kate F, Naafs B. Bullous pemphigoid in children. Report of three cases with special emphasis on therapy. Int J Dermatol 1991; 30: 339-342.
https://doi.org/10.1111/j.1365-4362.1991.tb03871.x DOI: https://doi.org/10.1111/j.1365-4362.1991.tb03871.x
Cambazard F, Thivolet J, Mironneau P. Bullous pemphigoid in a 4-month-old boy. Br J Dermatol 1994; 131: 449-451.
https://doi.org/10.1111/j.1365-2133.1994.tb08540.x DOI: https://doi.org/10.1111/j.1365-2133.1994.tb08540.x
Bisherwal K, Pandhi D, Singal A, Sharma S. Infantile bullous pemphigoid following vaccination. Indian Pediatr 2016; 53: 425-426.
https://doi.org/10.1007/s13312-016-0867-3 DOI: https://doi.org/10.1007/s13312-016-0867-3
Guerra L, Pedicelli C, Fania L, De Luca N, Condorelli AG, Mazzanti C, et al. Infantile bullous pemphigoid following vaccination. Eur J Dermatol 2018; 28: 708-710.
https://doi.org/10.1684/ejd.2018.3383 DOI: https://doi.org/10.1684/ejd.2018.3383
Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver 2010; 4: 1-14.
https://doi.org/10.5009/gnl.2010.4.1.1 DOI: https://doi.org/10.5009/gnl.2010.4.1.1
Kiehl P, Falkenberg K, Vogelbruch M, Kapp A. Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol 2001; 145: 720-729.
https://doi.org/10.1046/j.1365-2133.2001.04456.x DOI: https://doi.org/10.1046/j.1365-2133.2001.04456.x
Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev 2003; 2003: Cd004056.
https://doi.org/10.1002/14651858.CD004056 DOI: https://doi.org/10.1002/14651858.CD004056
Mayuzumi M, Akiyama M, Nishie W, Ukae S, Abe M, Sawamura D, et al. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature. Br J Dermatol 2006; 155: 1048-1052.
https://doi.org/10.1111/j.1365-2133.2006.07443.x DOI: https://doi.org/10.1111/j.1365-2133.2006.07443.x
Arora S, Shetty VM, Rao CR, Pai SB, Rao R. Serration pattern analysis as a practical adjunct tool for categorization of subepidermal autoimmune blistering diseases. Indian J Dermatol Venereol Leprol 2021; 87: 778-786.
https://doi.org/10.25259/IJDVL_1232_20 DOI: https://doi.org/10.25259/IJDVL_1232_20
Additional Files
Published
How to Cite
License
Copyright (c) 2024 Yuexin Zhang, Jingyang Dang, Ruoyu Li, Xixue Chen, Xuejun Zhu, Mingyue Wang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
